Evaluation of Serum Endocan Levels in Patients With Gestational Diabetes
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 90
- Locations
- 2
- Primary Endpoint
- Detection of diagnostic value of serum endocan levels in patient with gestational diabetes
Study Overview
Brief Summary
In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.
Detailed Description
It has been shown that endocan level of plasental tissue in gestational diabtes patients is significantly increased when looking at the same week compared with plasenta tissue samples of helathy pregnancy. From the information obtained from these studies, it can be said that there is a strong association between diabetes mellitus and serum endocan levels. investigators aimed to determine the relationship between serum endocan levels and gestational diabetes in the study.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •being pregnant at 24-26 weeks of gestation
- •having oral glucose toleranse screening test
- •age between 18-45 years
Exclusion Criteria
- •having in utero mort fetus
- •having a previous diagnosis of diabetes
- •having a multiple pregnancy
- •having a coronary artery disease
- •having preeclampcia
- •having a pregnancy obtained by assisted reproductive technology
- •using cigarette
- •using alcohol
Outcomes
Primary Outcomes
Detection of diagnostic value of serum endocan levels in patient with gestational diabetes
Time Frame: 3 months
Identifying diagnostic value of serum endocan by comparing serum levels of endocan in groups.
Secondary Outcomes
No secondary outcomes reported
Investigators
Elif Yıldız
Principal investigator
Gaziosmanpasa Research and Education Hospital